miércoles, 10 de febrero de 2016

NIAID Funding News, February 10, 2016


February 10, 2016 NIAID Funding News

Feature Articles 

Why You May Want to Consider a Contract

If you're unfamiliar with the world of research and development contracts, a little context may build your enthusiasm when you see solicitations well-suited to your scientific strengths.

Opportunities and Resources

New Funding Initiative Encourages Collaboration With Brazilian Researchers

NIH and the São Paulo Research Foundation have signed a memorandum of understanding to encourage collaborative international research between investigators in the U.S. and the State of São Paulo, Brazil.

Supplements Available to Support Research on Sex and Gender Differences

NIH is offering administrative supplements to support research highlighting the impact of sex and gender differences, similarities, and factors in human health and illness.

Funding for Ethics Education in Low- and Middle-Income Countries

A recently reissued funding opportunity announcement could help establish sustainable, graduate-level research ethics training at your research-intensive, Low- or Middle-Income Country institution.

In The News

Zika Virus Research Is a High Priority

NIAID is highly interested in funding research and product development for Zika virus (ZIKV).

Mine Immunology Data on New ImmuneSpace Website

You can now access and analyze data from the Human Immunology Project Consortium online through ImmuneSpace.

NIH Reissues Parent K99/R00 With Clarified Instructions

If you plan to apply for the NIH Pathway to Independence Award (Parent K99/R00), be sure to use the reissued funding opportunity announcement.

News Briefs


Advice Corner

Initiate the Investigator-Initiated Clinical Trial Process Soon

Researchers who are considering an investigator-initiated clinical trial (IICT) should know that May 13, 2016, is the next deadline for IICT applications.

Reader Questions


New Funding Opportunities

See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to deaweb@niaid.nih.gov.

No hay comentarios: